Search

Your search keyword '"Merghoub, Taha' showing total 63 results

Search Constraints

Start Over You searched for: Author "Merghoub, Taha Remove constraint Author: "Merghoub, Taha Publisher elsevier inc. Remove constraint Publisher: elsevier inc.
63 results on '"Merghoub, Taha'

Search Results

1. Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma

4. Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

5. MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma

6. Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade

7. T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants

8. The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer

10. Pharmacologic modulation of RNA splicing enhances anti-tumor immunity

11. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors

12. Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity

14. Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

15. Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition

18. Chapter 6 - Surrogate assessment of brain health using longitudinal measures of blood-based biomarkers in short-duration human spaceflight

19. Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade

22. Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient

23. HMG-CoA synthase 1 is a synthetic lethal partner of BRAFV600E in human cancers

25. Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth

29. Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses

30. Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling

33. List of contributors

40. A Pilot Study Evaluating Lenalidomide and CC-486 in Combination with Radiotherapy for Patients with Plasmacytoma (LENAZART study)

50. Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses

Catalog

Books, media, physical & digital resources